Julian Chick
Chairman at CANN GROUP LIMITED
Profile
Julian J.
Chick is currently the Chairman at Cann Group Ltd.
He also holds positions as a Director at Mid-Atlantic BioTherapeutics, Inc. and as an Independent Non-Executive Director at LTR Pharma Ltd.
Previously, he served as the Chief Executive Officer & Director at Tali Digital Ltd.
from 2004 to 2010.
He was also the Chief Operating Officer & Director at Anteris Technologies Ltd.
Additionally, he worked as a Non-Executive Director at Opyl Ltd.
from 2019 to 2023.
Dr. Chick holds a doctorate degree from the University of Oxford and an undergraduate degree from LaTrobe University.
Julian Chick active positions
Companies | Position | Start |
---|---|---|
CANN GROUP LIMITED | Chairman | 2023-08-27 |
LTR PHARMA LIMITED | Director/Board Member | - |
Mid-Atlantic BioTherapeutics, Inc.
Mid-Atlantic BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mid-Atlantic BioTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. The company was founded by David Horn, David Jobes, and Jean-Pierre Gagnon in 2011 and is headquartered in Doylestown, PA. | Director/Board Member | - |
Former positions of Julian Chick
Companies | Position | End |
---|---|---|
OPYL LIMITED | Chairman | 2022-09-15 |
TALI DIGITAL LIMITED | Chief Executive Officer | 2010-05-30 |
ANTERIS TECHNOLOGIES LTD | Chief Operating Officer | - |
Training of Julian Chick
University of Oxford | Doctorate Degree |
LaTrobe University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
TALI DIGITAL LIMITED | Technology Services |
ANTERIS TECHNOLOGIES LTD | Health Technology |
OPYL LIMITED | Technology Services |
CANN GROUP LIMITED | Process Industries |
LTR PHARMA LIMITED | Health Technology |
Private companies | 1 |
---|---|
Mid-Atlantic BioTherapeutics, Inc.
Mid-Atlantic BioTherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mid-Atlantic BioTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases. The company was founded by David Horn, David Jobes, and Jean-Pierre Gagnon in 2011 and is headquartered in Doylestown, PA. | Commercial Services |
- Stock Market
- Insiders
- Julian Chick